TICKETS FOR PIVOTAL LINKS 2024 NOW ON SALE - SIGN UP NOW TO GUARANTEE YOUR PLACE

Ready to Exit – conduct a feasibility review first!

Exit Strategy 3

When it comes to mergers and acquisitions (M&A) within the life sciences industry, we believe in simplifying the process into manageable modules. Companies can choose to tackle these sections sequentially or concentrate on one area at a time. Our recommended modular approach—Feasibility, Engagement, and Completion—offers a gradual, step-by-step process enabling businesses to make any necessary … Read more

Life Science M&A: A Pivotal Scientific Perspective

Exot Strategy 2

Buy Side Continued investment from PE and Multinationals Post-pandemic there has been increased and sustained investment from private equity (PE) firms into the life sciences space, however the large multiples seen during and in the immediate aftermath of the pandemic have not stood the test of time. PE investment has come from both large and … Read more

The Abcore Story – Pivotal Scientific’s perspective from End-to-End

Exit Strategy 4

From establishing a gap in the market to diversifying revenue streams to raising valuable brand awareness, many companies find they need expert guidance and advice to help them reach their full potential. This is where Pivotal Scientific comes in, with an industry-leading team and a full suite of consultancy services, ready to help companies from … Read more

How to make the most of your PSL Alliance membership

Digital M 3

Use our resources The Pivotal Scientific website has plenty of resources to help members identify, filter through, and learn about potential future connections. Our interactive list of members can be narrowed down by product type, industry focus, or service, making it easier to find fellow PSL Alliance members, whom you might want to be introduced … Read more